STRATEGICALLIANCES
Going beyond providing direct client services, CCF has
forged strategic alliances with like-minded partners that
are alignedwith our mission to enhance the quality of life
of childrenwith cancer and their families.
In2014,CCFpledged$2.5million inastrategicpartnership
with The SingHealth Duke-NUS Paediatrics Academic
Clinical Programme to set up the Tan Cheng Lim-CCF
Professorship inPaediatricOncology.With dollar-to-dollar
matching from the Singapore government, the fund was
doubled to $5million. The endowedProfessorship aims to
advance the practice of paediatric medicine and improve
medical treatments through clinical research in childhood
cancers. The Professorship will also promote continued
learning and innovative medical research in the future
generations of paediatricians inSingapore.
By providing an excellent platform for collaborations with
international centres of excellence and leveraging the
expertise and resources of the SingHealth Duke-NUS
AcademicMedical CentreandKKH, theProfessorshipwill
help push the frontiers of clinical research in paediatric
oncology in Singapore and enhance future treatment and
patient care for children affected by childhood cancers.
CCFhadmade the initial contributionof $1million in2014,
with the second tranche of $750,000 disbursed in 2015.
TheProfessorshipwas officially launchedon25 July 2015
at the opening of CCF’s signature fundraising event, Hair
for Hope, at VivoCity.
CCF had also pledged $4 million to support the
establishment of the VIVA-NUS Centre for Translational
Research inAcute Leukaemia (VIVA-NUSCenTRAL) that
aims to improve the cure rate of leukaemia and treatment
outcomes.Thesecond trancheof $1millionwasdisbursed
in 2015.
CCF has also been a long standing partner of the annual
St.Jude-VIVA Forum since its inception in 2007. As
Learning Partner, CCF supports the continuous training
and education of local doctors, nurses and allied health
professionals at the Forum. In conjunction with the
9
th
St.Jude-Viva Forum, CCF and Viva Foundation for
Children with Cancer jointly organised the CCF-VIVA
Learning Xchange on 28 March 2015. Participants
had the opportunity to gain valuable insights into the
long-term effects of paediatric cancer therapy and the
use of traditional Chinese medicine as a complement to
western cancer therapy from oncology experts.
Overall, in 2015, CCF contributed a total of $2.3 million
in support of research and education in paediatric
oncology and other collaborations with medical partners
andorganisations suchasKKH, NUHandSingaporeCord
BloodBank.
21
